PUBLIC COMPANY
saveBRECKENRIDGE
USupdated 5mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Unknown
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- With Setara, the team behind Actio opens its second actThe fledgling startup has $90 million to develop a pipeline of drugs, led by a Charcot-Marie-Tooth disease medicine, that Actio was working on when Jazz Pharmaeuticals bought its lead epilepsy prog…biopharma_dive · 6d ago
- Jazz's $820M Actio buyout gives rise to Setara, armed with $90M series ASetara Biosciences, a privately held spinout formed following Jazz Pharmaceuticals' acquisition of Actio Biosciences in September, has raised $90 million in series A financing to advance its clinic…fiercebiotech · 7d ago
comments(0)
5-min edit window · permanent after that